TrialBMC cancer2018

Adjuvant treatment of resectable biliary tract cancer with cisplatin plus gemcitabine: A prospective single center phase II study.

Alexander R Siebenhüner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.